Unveiling the genus Taraxacum: From folk medicine to chemodiversity-driven pharmacological and toxicological outcomes-A systematic review
Clinical Snapshot
PICO Framework
| P — Population | Taraxacum genus (dandelion) species - 55 species examined with focus on traditional medicine applications |
| I — Intervention | Traditional medicinal preparations and phytochemical compounds from Taraxacum species |
| C — Comparator | Not applicable - descriptive systematic review of ethnopharmacological uses and chemical constituents |
| O — Outcomes | Ethnobotanical uses, phytochemical composition (380+ compounds), pharmacological activities (anti-cancer, anti-inflammatory, antioxidant), and toxicological safety profiles |
Bottom Line
This systematic review provides a comprehensive ethnopharmacological and phytochemical survey of the Taraxacum genus, documenting over 380 compounds across 55 species and confirming traditional uses for anti-inflammatory and digestive applications. While the scope is impressive and the chemical diversity well-documented, the review lacks critical methodological elements expected of high-quality systematic reviews, including formal quality assessment and quantitative synthesis. The authors appropriately acknowledge that current evidence, while supportive of traditional uses, remains insufficient for clinical recommendations. The favorable safety profile of common species (T. officinale, T. mongolicum) is reassuring for patients already using dandelion preparations. However, clinicians should be aware that most pharmacological evidence derives from in vitro studies, with limited human clinical data. The review highlights significant research gaps, particularly for cardiovascular and neurodegenerative applications, and calls for rigorous in vivo studies before therapeutic claims can be substantiated. For Australian practitioners, this represents valuable background knowledge for patient counselling about complementary medicine use rather than evidence supporting active clinical recommendation.
Key Findings
Effect Size: Not applicable - descriptive review without quantitative synthesis
Primary Outcome: Comprehensive cataloguing of 380+ phytochemical compounds across 55 Taraxacum species
Nnt Or Sensitivity: Safety profile established for T. officinale, T. mongolicum, and T. lacistrum with favorable toxicological outcomes
Confidence Interval: Not provided
Clinical Application
Limited by lack of standardised preparations and clinical trial evidence for most therapeutic applications Not currently listed on PBS; TGA regulation as complementary medicine would apply; limited integration with conventional Australian healthcare practice Patients seeking complementary medicine approaches for inflammatory conditions, digestive disorders, and as adjunctive therapy
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: The genus Taraxacum (dandelion), belonging to the Asteraceae family, encompasses over 2800 species predominantly found in temperate to subtropical regions of the Northern Hemisphere. Dandelion has a long history as a functional food and traditional medicine in numerous countries, including China, Turkey, Spain, Italy, etc. Traditional application records indicate that dandelion might be used extensively to treat kidney stones, constipation, eczema, ulcers, inflammation, etc. However, the therapeutic application of different Taraxacum species varies significantly across regions, which may be influenced by local cultural and medical traditions. AIM OF THE REVIEW: This review provides a comprehensive summary of recent advancements in traditional applications, phytochemistry (highlighting 184 newly identified compounds), pharmacology, and toxicology, offering novel insights into both genus-wide characteristics of Taraxacum (covering 55 species) and species-specific differences. MATERIALS AND METHODS: A comprehensive search for relevant data was conducted using keywords such as "Taraxacum", "dandelion", "Taraxaci Herba", "pu gong ying", and others across multiple scientific databases, including Google Scholar, Web of Science, PubMed, ScienceDirect, Baidu Scholar, CNKI, online ethnobotanical databases, ethnobotanical monographs, The Plant List, Dictionary of Chinese Ethnic Medicine and considered data from 1972 to 2025. World Flora Online (http://www.worldfloraonline.org/) was utilized for confirming the correct species names of Taraxacum genus. The gathered information on the ethnobotanical usages, phytochemistry, pharmacology, and toxicology is comprehensively summarized in this paper. RESULTS: The literature review indicates that dandelion, a medicinal and edible plant, has been extensively utilized in traditional Chinese medicine since the 7th century. In Europe, its edible and medicinal properties began to be acknowledged and applied during the Middle Ages. In ethnomedical practice, dandelion has been used as diuretic, laxative, anti-inflammatory remedy, digestive aid, etc. Building on the 197 compounds reported from T. officinale, this review highlights over 180 newly identified compounds from 19 Taraxacum species, expanding the genus-wide catalog to more than 380 constituents. Recent toxicological and safety evaluations corroborate that T. officinale F.H.Wigg., T. mongolicum Hand.-Mazz., and T. lacistrum Sahlin possess a favorable safety profile. CONCLUSIONS: The genus Taraxacum is a promising medicinal and edible plant, exhibiting a range of biological activities, including anti-cancer, anti-inflammatory, and antioxidant effects. These properties align with its ethnobotanical usages, confirming its traditional use as diuretic, laxative, anti-inflammation, and digestive aid. However, research on its effects on neurodegenerative and cardiovascular diseases remains limited. Future studies should focus on in vivo experiments to explore the material basis and mechanisms underlying the therapeutic effects of dandelion species. Furthermore, current phytochemical and pharmacological research has overlooked several Taraxacum species with well-documented traditional uses. Investigating these understudied species is essential to fully elucidate the potential therapeutic value of the genus Taraxacum.
References
- 1.Cui, M., Wang, X., Yu, T., Liu, X., & Zhang, X. (2026). Unveiling the genus Taraxacum: From folk medicine to chemodiversity-driven pharmacological and toxicological outcomes-A systematic review. Journal of Ethnopharmacology, 121231. https://doi.org/10.1016/j.jep.2026.121231
Related Research
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Facilitators and barriers to the implementation of traditional Chinese exercises in cancer patients: a mixed-methods systematic review
25 May 2026
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Acupuncture for chemotherapy-induced dysgeusia (AcuDysg): a randomized controlled trial
14 May 2026
Journal of ethnopharmacology
Advances in the pharmacology and mechanism of anti-skin aging in Tonifying Traditional Chinese Medicines
12 May 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service